Trastuthera
is used in the treatment of certain types of cancer associated with overexpression of HER2 receptors. It contains an
active ingredient that helps inhibit the growth of cancer cells and reduce their spread.
The medication is commonly used as part of specific treatment protocols under the supervision of a specialized
physician.
The drug helps improve treatment response in some patients and is administered through intravenous infusion in
specialized medical centers with continuous monitoring of the patient’s health condition.
Composition of Trastuthera
Trastuthera contains the following active ingredient:
Dosage Forms of Trastuthera
Trastuthera is available as a powder vial used for preparing an intravenous infusion solution at a strength of 440 mg.
It is considered an antineoplastic therapy used under specialized medical supervision.
Indications for TRASTUTHERA
The main uses of Trastuthera include:
Treatment of HER2-positive breast cancer
Treatment of certain HER2-positive gastric cancer cases
Reducing the spread of cancer cells
Use as part of chemotherapy protocols
Helping improve therapeutic response in some tumors
Dosage of Trastuthera
The medication is administered through intravenous infusion under specialized medical supervision. The dosage varies
according to the patient’s body weight, type of tumor, and overall health condition.
The number of treatment sessions is determined according to the patient’s response to therapy and the physician’s
evaluation. A loading dose may be used at the beginning of treatment to achieve the required therapeutic
concentration.
It is important to strictly adhere to the prescribed treatment schedule and infusion sessions to ensure the best
possible therapeutic outcomes.
Side Effects of Trastuthera
The most common side effects of Trastuthera include:
Fever and chills
Nausea and vomiting
Fatigue and exhaustion
Headache
Diarrhea
Decreased blood cell count
Shortness of breath in some cases
Cardiac function disorders in certain patients
Contraindications of Trastuthera
Trastuthera should not be used in cases of hypersensitivity to trastuzumab or any of the product ingredients.
The medication should also be avoided in patients with severe heart failure unless under strict medical supervision.
Caution is required in patients with lung or liver disorders.
Patients should inform their doctor about all medications being used before starting treatment.
Alternatives to Trastuthera in Pharmacies
Available alternatives include:
Herceptin
Hertraz
Ogivri
Hervive
Treatment should not be discontinued without consulting the physician.
Use During Pregnancy and Breastfeeding
The medication should be used with extreme caution during pregnancy and breastfeeding. It is contraindicated during
pregnancy except in cases of absolute medical necessity and under close medical supervision.
An effective method of contraception should be used throughout the treatment period, and the doctor should be informed
immediately if pregnancy occurs during therapy.
Breastfeeding is generally not recommended during treatment. Medical consultation is advised before planning pregnancy
to ensure safety and proper evaluation of the condition.
Storage Conditions
The medication should be stored under the following conditions:
Store in a refrigerator at the recommended temperature
Do not freeze
Keep inside the original package
Protect from direct light
Keep out of reach of children